SANA Stock Analysis: Buy, Sell, or Hold?
SANA - Sana Biotechnology, Inc. Common Stock
$3.61
-0.04 (-0.96%)
βΌ
5d:
-12.5%
30d:
+30.14%
90d:
+12.31%
WAIT
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 10, 2026
26d
Get Alerted When SANA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: SANA is down 12.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: SANA is down 12.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: SANA is currently trading at $3.60, which is considered slightly high relative to its 30-day fair value range of $2.84 to $3.77.
Technical Outlook: Technically, SANA is in a uptrend. Immediate support is located at $3.39, while resistance sits at $4.21.
Market Sentiment: SANA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.57 (+135.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SANA is in a uptrend. Immediate support is located at $3.39, while resistance sits at $4.21.
Market Sentiment: SANA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.57 (+135.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$2.84 -
$3.77
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
78.9%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 135.5% below Wall St target ($8.57)
- WARNING: Recommendation downgraded due to -12.5% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$2.84 -
$3.77
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$3.39
Resistance Level
$4.21
Current Trend
Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.97
Wall Street Target
$8.57
(+135.5%)
Share & Embed Analysis
Last updated: July 14, 2026 11:43 AM ET
Data refreshes hourly during market hours. Next update: 12:43 PM
Data refreshes hourly during market hours. Next update: 12:43 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SANA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 54 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$413 | 54 HOLD |
|
REGN
Regeneron Pharmaceutical⦠|
STRONG BUY
25 analysts |
$822 | 64 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I⦠|
STRONG BUY
18 analysts |
$9 | 62 BUY |